UPLC with the SELECT SERIES™ MRT for Metabolite Identification

Importance of the Topic

High-performance liquid chromatography coupled with ultra-high resolution time-of-flight mass spectrometry is indispensable for elucidating drug metabolism in complex biological matrices. Achieving part-per-billion mass accuracy and resolving isobaric interferences enhances confidence in metabolite identification, supporting regulatory requirements, forensic toxicology, QA/QC and drug development workflows.

Objectives and Study Overview

This study evaluates the capability of an ACQUITY UPLC I-Class system paired with the SELECT SERIES™ MRT hybrid quadrupole multi-reflecting time-of-flight mass spectrometer for non-targeted screening and targeted metabolite profiling in human urine. Key aims include assessing chromatographic performance, mass accuracy and informatics integration in a routine workflow.

Methodology and Instrumentation

Sample Preparation:

• Human urine diluted 1:10 in water and spiked with a system suitability test (SST) mix (1–1000 pg/µL) containing acetaminophen, caffeine, sulphadimethoxine, terfenadine, verapamil, leucine enkephalin and reserpine.
• Volunteer dosing: acetaminophen (2×500 mg), naproxen (1×500 mg) and carbamazepine (2×200 mg); samples collected 6 h post-dose.

LC Conditions:

• Instrument: Waters ACQUITY UPLC I-Class
• Column: ACQUITY UPLC HSS T3 C18 (100 × 2.1 mm, 1.8 µm) at 40 °C
• Mobile phase A: water with 0.1% formic acid; B: acetonitrile with 0.1% formic acid; flow rate: 0.5 mL/min; injection: 5 µL
• Gradient: 1% B to 95% B over 9 min, re-equilibration to 1% B by 12 min.

MS Conditions:

• Instrument: SELECT SERIES™ MRT Q-MR-TOF (200 000 FWHM resolution)
• Ionization: ESI positive mode; capillary 0.5 kV; source 150 °C; desolvation 550 °C; cone 20 V
• Mass range: m/z 50–2400; acquisition rate: 10 Hz; software: MassLynx v4.2 and waters_connect™ 1.94.

Main Results and Discussion

• Acetaminophen and its sulfate/glucuronide conjugates were resolved with fragment mass error <70 ppb.
• Naproxen glucuronide fragment spectra showed <200 ppb mass error at continuum resolution.
• Carbamazepine and epoxide metabolite measurements exhibited sub-300 ppb errors.
• Combined data (N=82) yielded an overall RMS error of 491 ppb.
• SST linearity in urine matrix delivered R² > 0.99 and RMS errors <500 ppb.
These results demonstrate robust chromatographic integrity, high mass accuracy and resolving power for low-level metabolite detection in biofluids.

Benefits and Practical Applications of the Method

• Separation of isobaric endogenous and exogenous species enhances structural assignment.
• Part-per-billion mass accuracy supports confident metabolite identification.
• High acquisition speed (10 Hz) enables efficient non-targeted workflows.
• Integration with advanced informatics accelerates data processing and reporting.

Future Trends and Potential Applications

• Integration of machine learning and AI-driven spectral annotation.
• Extension to comprehensive profiling of endogenous metabolites and biomarkers.
• Development of real-time monitoring and miniaturized platforms for point-of-care applications.
• Application in personalized medicine, environmental toxicology and food safety.

Conclusion

The combination of UPLC with the SELECT SERIES™ MRT delivers exceptional resolution, mass accuracy and throughput, facilitating accurate and efficient metabolite identification in complex biological matrices. This platform, paired with modern informatics, provides a powerful solution for pharmaceutical research, toxicology and quality control applications.